| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.873 | 0.007 | 0.921 | Antiinflammatory | 0.857 0.009 DBMET00151 0.921 0.005 DBMET00152 | DBMET00152 | |
| 0.715 | 0.003 | 0.715 | Amyloid beta precursor protein antagonist | 0.699 0.003 DBMET00151 0.299 0.017 DBMET00152 | ||
| 0.677 | 0.004 | 0.677 | Cyclooxygenase 1 inhibitor | 0.645 0.004 DBMET00151 0.418 0.006 DBMET00152 | ||
| 0.671 | 0.016 | 0.671 | Analgesic | 0.632 0.022 DBMET00151 0.412 0.079 DBMET00152 | ||
| 0.645 | 0.004 | 0.862 | Non-steroidal antiinflammatory agent | 0.648 0.004 DBMET00151 0.862 0.003 DBMET00152 | DBMET00152 | |
| 0.624 | 0.023 | 0.789 | Cyclophilin D inhibitor | 0.599 0.027 DBMET00151 0.789 0.007 DBMET00152 | DBMET00152 | |
| 0.563 | 0.013 | 0.563 | Nootropic | 0.481 0.023 DBMET00151 | ||
| 0.528 | 0.014 | 0.736 | Antiamyloidogenic | 0.595 0.008 DBMET00151 0.736 0.004 DBMET00152 | DBMET00152 | |
| 0.517 | 0.007 | 0.517 | Anesthetic general | 0.515 0.007 DBMET00151 0.448 0.012 DBMET00152 | ||
| 0.504 | 0.005 | 0.504 | Cyclooxygenase inhibitor | 0.473 0.005 DBMET00151 0.335 0.013 DBMET00152 | ||
| 0.478 | 0.036 | 0.663 | Cholesterol antagonist | 0.526 0.029 DBMET00151 0.663 0.011 DBMET00152 | DBMET00152 | |
| 0.433 | 0.015 | 0.433 | Calcium channel activator | 0.423 0.017 DBMET00151 | ||
| 0.42 | 0.005 | 0.471 | Chelator | 0.471 0.005 DBMET00151 0.151 0.035 DBMET00152 | DBMET00151 | |
| 0.421 | 0.022 | 0.421 | Hypolipemic | 0.397 0.026 DBMET00151 0.413 0.023 DBMET00152 | ||
| 0.412 | 0.014 | 0.42 | Sodium/bile acid cotransporter inhibitor | 0.42 0.012 DBMET00151 0.403 0.016 DBMET00152 | DBMET00151 | |
| 0.401 | 0.007 | 0.401 | Interleukin 6 antagonist | 0.382 0.008 DBMET00151 0.237 0.026 DBMET00152 | ||
| 0.409 | 0.026 | 0.598 | Hypoglycemic | 0.442 0.022 DBMET00151 0.598 0.008 DBMET00152 | DBMET00152 | |
| 0.405 | 0.026 | 0.45 | Superoxide dismutase inhibitor | 0.45 0.019 DBMET00151 | DBMET00151 | |
| 0.428 | 0.053 | 0.569 | Immunosuppressant | 0.412 0.058 DBMET00151 0.569 0.017 DBMET00152 | DBMET00152 | |
| 0.41 | 0.041 | 0.532 | Immunomodulator | 0.342 0.062 DBMET00151 0.532 0.019 DBMET00152 | DBMET00152 | |
| 0.384 | 0.027 | 0.468 | Amyloid beta aggregation inhibitor | 0.468 0.017 DBMET00151 0.233 0.063 DBMET00152 | DBMET00151 | |
| 0.362 | 0.008 | 0.362 | Cyclooxygenase 2 inhibitor | 0.338 0.009 DBMET00151 0.236 0.023 DBMET00152 | ||
| 0.367 | 0.021 | 0.367 | 5 Hydroxytryptamine uptake stimulant | 0.36 0.023 DBMET00151 | ||
| 0.337 | 0.005 | 0.592 | Cyclooxygenase 3 inhibitor | 0.386 0.004 DBMET00151 0.592 0.002 DBMET00152 | DBMET00152 | |
| 0.339 | 0.014 | 0.339 | Gastrin inhibitor | 0.295 0.037 DBMET00151 0.227 0.109 DBMET00152 | ||
| 0.322 | 0.01 | 0.322 | Insulin secretagoues | 0.295 0.013 DBMET00151 0.315 0.011 DBMET00152 | ||
| 0.332 | 0.033 | 0.332 | Anticonvulsant | 0.196 0.086 DBMET00151 | ||
| 0.303 | 0.016 | 0.367 | Alpha-N-acetylglucosaminidase inhibitor | 0.224 0.028 DBMET00151 0.367 0.011 DBMET00152 | DBMET00152 | |
| 0.3 | 0.014 | 0.3 | Histone acetyltransferase inhibitor | 0.296 0.014 DBMET00151 | ||
| 0.359 | 0.074 | 0.75 | Transcription factor NF kappa B inhibitor | 0.457 0.052 DBMET00151 0.75 0.016 DBMET00152 | DBMET00152 | |
| 0.291 | 0.007 | 0.321 | ATPase inhibitor | 0.293 0.007 DBMET00151 0.321 0.005 DBMET00152 | DBMET00152 | |
| 0.289 | 0.009 | 0.289 | Ferrochelatase inhibitor | 0.159 0.034 DBMET00151 | ||
| 0.265 | 0.007 | 0.349 | Alcohol dehydrogenase inhibitor | 0.349 0.004 DBMET00151 0.116 0.037 DBMET00152 | DBMET00151 | |
| 0.299 | 0.048 | 0.426 | Interleukin agonist | 0.28 0.059 DBMET00151 0.426 0.015 DBMET00152 | DBMET00152 | |
| 0.297 | 0.048 | 0.355 | Interleukin antagonist | 0.355 0.038 DBMET00151 | DBMET00151 | |
| 0.323 | 0.075 | 0.587 | Antithrombotic | 0.323 0.075 DBMET00151 0.587 0.018 DBMET00152 | DBMET00152 | |
| 0.275 | 0.028 | 0.31 | Thrombolytic | 0.26 0.031 DBMET00151 0.31 0.022 DBMET00152 | DBMET00152 | |
| 0.272 | 0.027 | 0.272 | Lipocortins synthesis antagonist | 0.248 0.034 DBMET00151 0.199 0.057 DBMET00152 | ||
| 0.26 | 0.017 | 0.26 | Interleukin 1 antagonist | 0.242 0.02 DBMET00151 0.119 0.09 DBMET00152 | ||
| 0.242 | 0.011 | 0.242 | GABA receptor agonist | 0.196 0.019 DBMET00151 | ||
| 0.238 | 0.007 | 0.244 | Interleukin 8 antagonist | 0.244 0.006 DBMET00151 | DBMET00151 | |
| 0.277 | 0.046 | 0.327 | Tyrosine 3 hydroxylase inhibitor | 0.327 0.022 DBMET00151 | DBMET00151 | |
| 0.245 | 0.019 | 0.309 | Aldehyde dehydrogenase inhibitor | 0.309 0.011 DBMET00151 0.155 0.045 DBMET00152 | DBMET00151 | |
| 0.362 | 0.136 | 0.525 | Caspase 9 stimulant | 0.424 0.097 DBMET00151 0.525 0.051 DBMET00152 | DBMET00152 | |
| 0.233 | 0.01 | 0.236 | Arachidonic acid antagonist | 0.236 0.009 DBMET00151 0.158 0.079 DBMET00152 | DBMET00151 | |
| 0.222 | 0.005 | 0.222 | Sphingosine 1-phosphate receptor 5 antagonist | 0.212 0.007 DBMET00151 | ||
| 0.293 | 0.079 | 0.48 | Interleukin 2 agonist | 0.305 0.07 DBMET00151 0.48 0.011 DBMET00152 | DBMET00152 | |
| 0.284 | 0.08 | 0.378 | Lipoxygenase inhibitor | 0.378 0.043 DBMET00151 | DBMET00151 | |
| 0.206 | 0.009 | 0.206 | ABCA1 expression enhancer | 0.186 0.011 DBMET00151 | ||
| 0.227 | 0.032 | 0.227 | Succinate dehydrogenase inhibitor | 0.22 0.035 DBMET00151 | ||
| 0.207 | 0.012 | 0.207 | GABA C receptor antagonist | 0.186 0.016 DBMET00151 | ||
| 0.317 | 0.123 | 0.65 | Antibacterial | 0.359 0.097 DBMET00151 0.65 0.013 DBMET00152 | DBMET00152 | |
| 0.201 | 0.01 | 0.201 | Glutamate receptor agonist | 0.126 0.024 DBMET00151 | ||
| 0.201 | 0.011 | 0.28 | Triose-phosphate isomerase inhibitor | 0.162 0.017 DBMET00151 0.28 0.005 DBMET00152 | DBMET00152 | |
| 0.2 | 0.012 | 0.2 | HIV-1 integrase (Overall Integration) inhibitor | 0.193 0.013 DBMET00151 | ||
| 0.194 | 0.009 | 0.194 | Sphingosine 1-phosphate receptor 2 antagonist | 0.188 0.011 DBMET00151 | ||
| 0.22 | 0.037 | 0.22 | Antipruritic | 0.216 0.039 DBMET00151 | ||
| 0.303 | 0.122 | 0.402 | Histamine release inhibitor | 0.353 0.098 DBMET00151 0.402 0.074 DBMET00152 | DBMET00152 | |
| 0.197 | 0.018 | 0.353 | Beta amyloid protein antagonist | 0.191 0.019 DBMET00151 0.353 0.004 DBMET00152 | DBMET00152 | |
| 0.214 | 0.036 | 0.352 | NOS3 expression enhancer | 0.277 0.021 DBMET00151 0.352 0.011 DBMET00152 | DBMET00152 | |
| 0.208 | 0.031 | 0.239 | Hexokinase inhibitor | 0.214 0.028 DBMET00151 0.239 0.019 DBMET00152 | DBMET00152 | |
| 0.295 | 0.12 | 0.295 | Antiobesity | 0.244 0.162 DBMET00151 0.268 0.141 DBMET00152 | ||
| 0.178 | 0.005 | 0.178 | Glutamate (mGluR7) agonist | 0.135 0.019 DBMET00151 | ||
| 0.254 | 0.081 | 0.641 | Antioxidant | 0.369 0.041 DBMET00151 0.641 0.009 DBMET00152 | DBMET00152 | |
| 0.187 | 0.017 | 0.201 | Mucolytic | 0.201 0.013 DBMET00151 0.197 0.014 DBMET00152 | DBMET00151 | |
| 0.174 | 0.004 | 0.197 | Liver X receptor alpha agonist | 0.197 0.004 DBMET00151 | DBMET00151 | |
| 0.187 | 0.018 | 0.228 | Potassium channel (Ca-activated) activator | 0.228 0.01 DBMET00151 | DBMET00151 | |
| 0.187 | 0.018 | 0.187 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.137 0.031 DBMET00151 0.173 0.021 DBMET00152 | ||
| 0.168 | 0.004 | 0.172 | CXC chemokine 1 receptor antagonist | 0.172 0.004 DBMET00151 | DBMET00151 | |
| 0.179 | 0.019 | 0.179 | Catalase inhibitor | 0.149 0.026 DBMET00151 | ||
| 0.22 | 0.061 | 0.474 | Nitric oxide antagonist | 0.265 0.048 DBMET00151 0.474 0.018 DBMET00152 | DBMET00152 | |
| 0.192 | 0.035 | 0.207 | Mannose-6-phosphate isomerase inhibitor | 0.177 0.044 DBMET00151 0.207 0.027 DBMET00152 | DBMET00152 | |
| 0.31 | 0.154 | 0.318 | 5 Hydroxytryptamine release inhibitor | 0.318 0.145 DBMET00151 0.266 0.206 DBMET00152 | DBMET00151 | |
| 0.163 | 0.007 | 0.182 | Glutamate release inhibitor | 0.155 0.009 DBMET00151 0.182 0.005 DBMET00152 | DBMET00152 | |
| 0.176 | 0.021 | 0.176 | Pregnane X receptor agonist | 0.168 0.028 DBMET00151 | ||
| 0.214 | 0.068 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 DBMET00151 0.201 0.087 DBMET00152 | DBMET00151 | |
| 0.155 | 0.01 | 0.155 | Lanosterol 14 alpha demethylase inhibitor | 0.147 0.012 DBMET00151 | ||
| 0.172 | 0.027 | 0.172 | GABA C receptor agonist | 0.135 0.041 DBMET00151 | ||
| 0.148 | 0.004 | 0.148 | Glutamate (mGluR3) antagonist | 0.098 0.004 DBMET00151 | ||
| 0.152 | 0.01 | 0.152 | Prostaglandin antagonist | 0.092 0.019 DBMET00151 | ||
| 0.271 | 0.13 | 0.271 | Toll-Like receptor 7 agonist | 0.241 0.155 DBMET00151 | ||
| 0.174 | 0.034 | 0.204 | Cholesterol synthesis inhibitor | 0.204 0.026 DBMET00151 0.119 0.066 DBMET00152 | DBMET00151 | |
| 0.172 | 0.034 | 0.248 | Cell adhesion inhibitor | 0.143 0.051 DBMET00151 0.248 0.015 DBMET00152 | DBMET00152 | |
| 0.188 | 0.053 | 0.208 | Phospholipase C inhibitor | 0.208 0.039 DBMET00151 0.156 0.095 DBMET00152 | DBMET00151 | |
| 0.267 | 0.133 | 0.267 | Toll-Like receptor agonist | 0.236 0.161 DBMET00151 | ||
| 0.182 | 0.049 | 0.316 | Interferon gamma antagonist | 0.215 0.036 DBMET00151 0.316 0.018 DBMET00152 | DBMET00152 | |
| 0.133 | 0.004 | 0.133 | Diacylglycerol O-acyltransferase inhibitor | 0.092 0.009 DBMET00151 | ||
| 0.203 | 0.074 | 0.243 | Neurotrophic factor enhancer | 0.243 0.043 DBMET00151 0.176 0.102 DBMET00152 | DBMET00151 | |
| 0.15 | 0.021 | 0.194 | DOPA decarboxylase inhibitor | 0.194 0.007 DBMET00151 | DBMET00151 | |
| 0.16 | 0.032 | 0.372 | Expectorant | 0.181 0.025 DBMET00151 0.372 0.005 DBMET00152 | DBMET00152 | |
| 0.14 | 0.014 | 0.14 | Prostaglandin-E synthase inhibitor | 0.123 0.018 DBMET00151 | ||
| 0.22 | 0.094 | 0.344 | DNA synthesis inhibitor | 0.225 0.088 DBMET00151 0.344 0.032 DBMET00152 | DBMET00152 | |
| 0.129 | 0.005 | 0.149 | GABA B receptor agonist | 0.149 0.004 DBMET00151 | DBMET00151 | |
| 0.124 | 0.004 | 0.124 | Liver X receptor beta agonist | 0.117 0.004 DBMET00151 | ||
| 0.153 | 0.035 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.149 0.046 DBMET00151 0.163 0.02 DBMET00152 | DBMET00152 | |
| 0.135 | 0.019 | 0.161 | Cell adhesion molecule inhibitor | 0.098 0.036 DBMET00151 0.161 0.013 DBMET00152 | DBMET00152 | |
| 0.173 | 0.058 | 0.194 | Neurotensin receptor agonist | 0.194 0.038 DBMET00151 | DBMET00151 | |
| 0.128 | 0.014 | 0.141 | Bile acid receptor antagonist | 0.141 0.009 DBMET00151 | DBMET00151 | |
| 0.124 | 0.01 | 0.166 | Glycine transporter 2 inhibitor | 0.166 0.007 DBMET00151 | DBMET00151 | |
| 0.125 | 0.011 | 0.125 | Sphingosine 1-phosphate receptor antagonist | 0.12 0.013 DBMET00151 | ||
| 0.172 | 0.058 | 0.186 | Phospholipase A2 inhibitor | 0.186 0.05 DBMET00151 0.127 0.105 DBMET00152 | DBMET00151 | |
| 0.118 | 0.004 | 0.118 | DNA helicase inhibitor | 0.106 0.005 DBMET00151 0.059 0.03 DBMET00152 | ||
| 0.159 | 0.046 | 0.195 | Toll-Like receptor 2 antagonist | 0.195 0.026 DBMET00151 | DBMET00151 | |
| 0.121 | 0.009 | 0.121 | Peroxisome proliferator-activated receptor gamma antagonist | 0.107 0.013 DBMET00151 | ||
| 0.133 | 0.023 | 0.139 | Thioredoxin inhibitor | 0.139 0.021 DBMET00151 0.129 0.025 DBMET00152 | DBMET00151 | |
| 0.165 | 0.058 | 0.211 | Protein kinase stimulant | 0.2 0.041 DBMET00151 0.211 0.038 DBMET00152 | DBMET00152 | |
| 0.107 | 0.004 | 0.107 | AICAR transformylase inhibitor | 0.099 0.005 DBMET00151 | ||
| 0.105 | 0.003 | 0.105 | Free fatty acid receptor 1 antagonist | 0.079 0.004 DBMET00151 | ||
| 0.239 | 0.139 | 0.393 | Apoptosis antagonist | 0.276 0.103 DBMET00151 0.393 0.04 DBMET00152 | DBMET00152 | |
| 0.139 | 0.039 | 0.155 | TRPA1 agonist | 0.155 0.028 DBMET00151 | DBMET00151 | |
| 0.144 | 0.045 | 0.157 | Vanilloid 1 agonist | 0.157 0.032 DBMET00151 0.13 0.066 DBMET00152 | DBMET00151 | |
| 0.203 | 0.103 | 0.322 | Aldehyde oxidase inhibitor | 0.322 0.061 DBMET00151 | DBMET00151 | |
| 0.119 | 0.02 | 0.119 | Peroxisome proliferator-activated receptor gamma agonist | 0.104 0.026 DBMET00151 | ||
| 0.103 | 0.004 | 0.103 | Glucagon receptor antagonist | 0.102 0.004 DBMET00151 | ||
| 0.157 | 0.06 | 0.315 | Cell wall synthesis inhibitor | 0.159 0.057 DBMET00151 0.315 0.009 DBMET00152 | DBMET00152 | |
| 0.136 | 0.039 | 0.136 | Nav1.1 sodium channel blocker | 0.132 0.041 DBMET00151 | ||
| 0.134 | 0.038 | 0.345 | AMP-activated protein kinase stimulant | 0.154 0.026 DBMET00151 0.345 0.004 DBMET00152 | DBMET00152 | |
| 0.101 | 0.005 | 0.101 | Retinoid X alpha receptor agonist | 0.072 0.009 DBMET00151 | ||
| 0.136 | 0.041 | 0.152 | Photosensitizer | 0.135 0.042 DBMET00151 0.152 0.03 DBMET00152 | DBMET00152 | |
| 0.304 | 0.208 | 0.304 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.1 | 0.005 | 0.116 | Nicotinic acid receptor agonist | 0.116 0.004 DBMET00151 | DBMET00151 | |
| 0.207 | 0.114 | 0.368 | Spasmolytic | 0.219 0.106 DBMET00151 0.368 0.047 DBMET00152 | DBMET00152 | |
| 0.126 | 0.034 | 0.15 | Prolactin inhibitor | 0.15 0.022 DBMET00151 | DBMET00151 | |
| 0.22 | 0.129 | 0.275 | Hypoxia-inducible factor 1 alpha inhibitor | 0.275 0.08 DBMET00151 | DBMET00151 | |
| 0.095 | 0.004 | 0.095 | Free fatty acid receptor 1 agonist | 0.058 0.005 DBMET00151 | ||
| 0.096 | 0.005 | 0.096 | Retinoid X receptor agonist | 0.078 0.008 DBMET00151 | ||
| 0.098 | 0.009 | 0.098 | Aconitate hydratase inhibitor | 0.064 0.023 DBMET00151 | ||
| 0.122 | 0.033 | 0.122 | MAP kinase kinase 1 inhibitor | 0.112 0.043 DBMET00151 | ||
| 0.125 | 0.037 | 0.182 | Creatine kinase inhibitor | 0.182 0.014 DBMET00151 | DBMET00151 | |
| 0.099 | 0.012 | 0.099 | Peroxisome proliferator-activated receptor alpha agonist | 0.085 0.016 DBMET00151 | ||
| 0.096 | 0.009 | 0.096 | Oleamide hydrolase inhibitor | 0.08 0.013 DBMET00151 | ||
| 0.101 | 0.014 | 0.101 | Phospholipase D inhibitor | 0.079 0.036 DBMET00151 | ||
| 0.11 | 0.025 | 0.163 | Keratolytic | 0.163 0.012 DBMET00151 | DBMET00151 | |
| 0.09 | 0.005 | 0.09 | AMPA 4 receptor antagonist | 0.07 0.008 DBMET00151 | ||
| 0.091 | 0.007 | 0.091 | Secretase gamma inhibitor | 0.063 0.017 DBMET00151 | ||
| 0.13 | 0.047 | 0.13 | Aminopeptidase B inhibitor | 0.113 0.057 DBMET00151 | ||
| 0.103 | 0.021 | 0.127 | Estrogen-related receptor beta agonist | 0.127 0.008 DBMET00151 | DBMET00151 | |
| 0.1 | 0.018 | 0.122 | Aldose reductase inhibitor | 0.122 0.014 DBMET00151 0.05 0.039 DBMET00152 | DBMET00151 | |
| 0.091 | 0.009 | 0.091 | Kinesin-like protein 1 inhibitor | 0.091 0.009 DBMET00151 | ||
| 0.091 | 0.009 | 0.091 | Kinesin antagonist | 0.091 0.009 DBMET00151 | ||
| 0.092 | 0.011 | 0.092 | Sphingosine 1-phosphate receptor 3 antagonist | 0.088 0.012 DBMET00151 | ||
| 0.102 | 0.023 | 0.111 | T cell inhibitor | 0.092 0.033 DBMET00151 0.111 0.017 DBMET00152 | DBMET00152 | |
| 0.13 | 0.051 | 0.203 | Cystathionine beta-synthase inhibitor | 0.203 0.024 DBMET00151 | DBMET00151 | |
| 0.093 | 0.014 | 0.093 | Glutamate (mGluR6) antagonist | 0.075 0.03 DBMET00151 | ||
| 0.109 | 0.03 | 0.182 | Macrophage migration inhibitory factor inhibitor | 0.182 0.009 DBMET00151 | DBMET00151 | |
| 0.109 | 0.03 | 0.109 | GABA A receptor agonist | 0.087 0.052 DBMET00151 | ||
| 0.152 | 0.077 | 0.309 | Peroxidase inhibitor | 0.309 0.036 DBMET00151 | DBMET00151 | |
| 0.119 | 0.044 | 0.119 | Adenylate kinase inhibitor | 0.098 0.07 DBMET00151 | ||
| 0.079 | 0.004 | 0.084 | Liver X receptor beta antagonist | 0.084 0.004 DBMET00151 | DBMET00151 | |
| 0.107 | 0.033 | 0.12 | Porphobilinogen synthase inhibitor | 0.12 0.028 DBMET00151 | DBMET00151 | |
| 0.099 | 0.025 | 0.1 | Amidase inhibitor | 0.1 0.024 DBMET00151 | DBMET00151 | |
| 0.102 | 0.028 | 0.127 | Glutamate decarboxylase inhibitor | 0.127 0.018 DBMET00151 | DBMET00151 | |
| 0.174 | 0.101 | 0.205 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.205 0.068 DBMET00151 | DBMET00151 | |
| 0.096 | 0.023 | 0.096 | Glycine receptor agonist | 0.088 0.03 DBMET00151 0.081 0.037 DBMET00152 | ||
| 0.098 | 0.026 | 0.126 | Phenylalanine 4-hydroxylase inhibitor | 0.126 0.016 DBMET00151 | DBMET00151 | |
| 0.095 | 0.024 | 0.103 | Leukotriene antagonist | 0.103 0.02 DBMET00151 0.06 0.051 DBMET00152 | DBMET00151 | |
| 0.086 | 0.014 | 0.086 | MDM2 inhibitor | 0.07 0.039 DBMET00151 | ||
| 0.086 | 0.016 | 0.086 | Dihydroorotate dehydrogenase inhibitor | 0.077 0.019 DBMET00151 | ||
| 0.098 | 0.029 | 0.158 | Estrogen receptor alpha antagonist | 0.158 0.011 DBMET00151 | DBMET00151 | |
| 0.072 | 0.004 | 0.072 | Retinoid X receptor antagonist | 0.064 0.005 DBMET00151 | ||
| 0.113 | 0.045 | 0.113 | Folate antagonist | 0.1 0.064 DBMET00151 | ||
| 0.076 | 0.008 | 0.076 | Peroxisome proliferator-activated receptor delta agonist | 0.054 0.011 DBMET00151 | ||
| 0.097 | 0.029 | 0.107 | GABA aminotransferase inhibitor | 0.107 0.023 DBMET00151 0.092 0.033 DBMET00152 | DBMET00151 | |
| 0.071 | 0.003 | 0.071 | G-protein-coupled receptor 120 agonist | 0.037 0.004 DBMET00151 | ||
| 0.094 | 0.028 | 0.116 | HIV-1 integrase inhibitor | 0.116 0.017 DBMET00151 | DBMET00151 | |
| 0.193 | 0.128 | 0.196 | 5 Hydroxytryptamine release stimulant | 0.196 0.124 DBMET00151 | DBMET00151 | |
| 0.104 | 0.04 | 0.104 | Ornithine decarboxylase inhibitor | 0.104 0.04 DBMET00151 | ||
| 0.076 | 0.013 | 0.085 | CD45 antagonist | 0.085 0.011 DBMET00151 | DBMET00151 | |
| 0.073 | 0.009 | 0.073 | Urate transporter 1 inhibitor | 0.07 0.01 DBMET00151 | ||
| 0.121 | 0.059 | 0.121 | Caspase 3 inhibitor | 0.117 0.065 DBMET00151 | ||
| 0.178 | 0.116 | 0.522 | Free radical scavenger | 0.321 0.046 DBMET00151 0.522 0.014 DBMET00152 | DBMET00152 | |
| 0.066 | 0.006 | 0.066 | Peroxisome proliferator-activated receptor alpha antagonist | 0.048 0.008 DBMET00151 | ||
| 0.12 | 0.061 | 0.338 | Monophenol monooxygenase inhibitor | 0.213 0.03 DBMET00151 0.338 0.014 DBMET00152 | DBMET00152 | |
| 0.178 | 0.119 | 0.313 | Platelet antagonist | 0.153 0.141 DBMET00151 0.313 0.049 DBMET00152 | DBMET00152 | |
| 0.063 | 0.004 | 0.063 | Retinoid X alpha receptor antagonist | 0.053 0.005 DBMET00151 | ||
| 0.092 | 0.033 | 0.092 | Aminopeptidase I inhibitor | 0.077 0.045 DBMET00151 | ||
| 0.168 | 0.109 | 0.175 | Insulin sensitizer | 0.175 0.101 DBMET00151 | DBMET00151 | |
| 0.113 | 0.054 | 0.165 | 5-Lipoxygenase inhibitor | 0.165 0.033 DBMET00151 | DBMET00151 | |
| 0.068 | 0.01 | 0.068 | G protein-coupled receptor agonist | 0.043 0.022 DBMET00151 | ||
| 0.064 | 0.007 | 0.064 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.03 0.019 DBMET00151 | ||
| 0.069 | 0.012 | 0.181 | Heparanase inhibitor | 0.065 0.016 DBMET00151 0.181 0.002 DBMET00152 | DBMET00152 | |
| 0.061 | 0.005 | 0.061 | Prostaglandin D2 antagonist | 0.031 0.011 DBMET00151 | ||
| 0.068 | 0.012 | 0.068 | Dihydroorotase inhibitor | 0.049 0.026 DBMET00151 | ||
| 0.065 | 0.011 | 0.075 | Dopamine beta hydroxylase inhibitor | 0.075 0.006 DBMET00151 | DBMET00151 | |
| 0.078 | 0.024 | 0.101 | Nitric oxide donor | 0.072 0.03 DBMET00151 0.101 0.008 DBMET00152 | DBMET00152 | |
| 0.063 | 0.01 | 0.063 | Glutamate (mGluR group II) antagonist | 0.047 0.018 DBMET00151 | ||
| 0.077 | 0.025 | 0.121 | Alcohol oxidase inhibitor | 0.121 0.014 DBMET00151 | DBMET00151 | |
| 0.181 | 0.13 | 0.185 | RNA-directed DNA polymerase inhibitor | 0.185 0.123 DBMET00151 | DBMET00151 | |
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | 0.05 0.012 DBMET00151 | ||
| 0.083 | 0.032 | 0.083 | Secretase beta inhibitor | 0.067 0.055 DBMET00151 | ||
| 0.074 | 0.024 | 0.074 | Thromboxane antagonist | 0.06 0.032 DBMET00151 | ||
| 0.055 | 0.007 | 0.055 | AMPA receptor agonist | 0.047 0.011 DBMET00151 | ||
| 0.063 | 0.015 | 0.063 | Liver X receptor agonist | 0.057 0.018 DBMET00151 | ||
| 0.063 | 0.015 | 0.063 | Sphingosine 1-phosphate receptor agonist | 0.05 0.025 DBMET00151 | ||
| 0.052 | 0.005 | 0.055 | CXC chemokine 2 receptor antagonist | 0.055 0.005 DBMET00151 | DBMET00151 | |
| 0.053 | 0.006 | 0.053 | Cholesterol ester transfer protein antagonist | 0.044 0.01 DBMET00151 | ||
| 0.141 | 0.095 | 0.18 | Melanin inhibitor | 0.18 0.051 DBMET00151 0.177 0.053 DBMET00152 | DBMET00151 | |
| 0.122 | 0.076 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | 0.143 0.041 DBMET00151 | DBMET00151 | |
| 0.068 | 0.023 | 0.102 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.102 0.01 DBMET00151 | DBMET00151 | |
| 0.058 | 0.014 | 0.058 | Glutamate (mGluR group III) antagonist | 0.044 0.03 DBMET00151 | ||
| 0.076 | 0.033 | 0.076 | Glutamate (mGluR7) antagonist | 0.07 0.043 DBMET00151 | ||
| 0.2 | 0.157 | 0.207 | Insulysin inhibitor | 0.207 0.146 DBMET00151 | DBMET00151 | |
| 0.127 | 0.085 | 0.127 | Nav1.6 sodium channel blocker | 0.111 0.109 DBMET00151 | ||
| 0.082 | 0.039 | 0.096 | Purinergic P2X2 antagonist | 0.096 0.032 DBMET00151 | DBMET00151 | |
| 0.072 | 0.03 | 0.107 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.107 0.015 DBMET00151 0.057 0.043 DBMET00152 | DBMET00151 | |
| 0.056 | 0.015 | 0.056 | Sphingosine 1-phosphate receptor 1 agonist | 0.046 0.024 DBMET00151 | ||
| 0.054 | 0.013 | 0.054 | Farnesoid X receptor agonist | 0.043 0.02 DBMET00151 | ||
| 0.049 | 0.008 | 0.062 | ATP citrate lysase inhibitor | 0.062 0.005 DBMET00151 | DBMET00151 | |
| 0.049 | 0.008 | 0.049 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET00151 | ||
| 0.089 | 0.049 | 0.102 | Vanilloid agonist | 0.102 0.031 DBMET00151 | DBMET00151 | |
| 0.097 | 0.056 | 0.127 | Uric acid excretion stimulant | 0.115 0.041 DBMET00151 0.127 0.034 DBMET00152 | DBMET00152 | |
| 0.063 | 0.024 | 0.063 | Pregnane X receptor antagonist | 0.062 0.027 DBMET00151 | ||
| 0.071 | 0.032 | 0.071 | Biliverdin reductase inhibitor | |||
| 0.058 | 0.019 | 0.058 | Cholesterol esterase inhibitor | 0.052 0.026 DBMET00151 | ||
| 0.053 | 0.014 | 0.053 | TRPM8 blocker | 0.035 0.03 DBMET00151 | ||
| 0.081 | 0.043 | 0.081 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET00151 | ||
| 0.047 | 0.009 | 0.047 | HMG CoA reductase inhibitor | 0.043 0.012 DBMET00151 0.037 0.019 DBMET00152 | ||
| 0.111 | 0.073 | 0.187 | Estrogen antagonist | 0.187 0.014 DBMET00151 | DBMET00151 | |
| 0.075 | 0.039 | 0.1 | Potassium channel large-conductance Ca-activated activator | 0.1 0.024 DBMET00151 | DBMET00151 | |
| 0.126 | 0.09 | 0.158 | Farnesoid X receptor antagonist | 0.158 0.044 DBMET00151 | DBMET00151 | |
| 0.157 | 0.121 | 0.157 | Platelet aggregation inhibitor | |||
| 0.068 | 0.033 | 0.084 | Transcription factor AP-1 inhibitor | 0.066 0.036 DBMET00151 0.084 0.019 DBMET00152 | DBMET00152 | |
| 0.044 | 0.012 | 0.044 | Dipeptidyl peptidase II inhibitor | |||
| 0.218 | 0.186 | 0.257 | GABA C receptor rho-3 antagonist | 0.257 0.148 DBMET00151 | DBMET00151 | |
| 0.041 | 0.009 | 0.041 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.085 | 0.054 | 0.085 | Inducible nitric-oxide synthase inhibitor | |||
| 0.04 | 0.009 | 0.042 | Liver X receptor alpha antagonist | 0.042 0.008 DBMET00151 | DBMET00151 | |
| 0.064 | 0.034 | 0.064 | Argininosuccinate synthase inhibitor | |||
| 0.044 | 0.014 | 0.044 | Vanilloid 3 antagonist | 0.041 0.019 DBMET00151 | ||
| 0.074 | 0.045 | 0.13 | Phosphofructokinase-1 inhibitor | 0.069 0.049 DBMET00151 0.13 0.022 DBMET00152 | DBMET00152 | |
| 0.047 | 0.018 | 0.047 | Kainate receptor agonist | 0.041 0.03 DBMET00151 | ||
| 0.088 | 0.059 | 0.169 | NADH dehydrogenase inhibitor | 0.087 0.062 DBMET00151 0.169 0.014 DBMET00152 | DBMET00152 | |
| 0.085 | 0.056 | 0.098 | D-Ala-D-Ala ligase inhibitor | 0.098 0.032 DBMET00151 | DBMET00151 | |
| 0.066 | 0.037 | 0.066 | Prostaglandin F2 alpha antagonist | 0.062 0.044 DBMET00151 | ||
| 0.052 | 0.024 | 0.074 | NMDA receptor subunit 3B antagonist | 0.074 0.015 DBMET00151 | DBMET00151 | |
| 0.051 | 0.023 | 0.051 | Macrophage elastase inhibitor | 0.041 0.033 DBMET00151 | ||
| 0.053 | 0.025 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 DBMET00151 0.064 0.016 DBMET00152 | DBMET00152 | |
| 0.063 | 0.035 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.041 | 0.013 | 0.042 | Liver X receptor antagonist | 0.042 0.013 DBMET00151 | DBMET00151 | |
| 0.065 | 0.038 | 0.065 | Caspase 9 inhibitor | 0.059 0.05 DBMET00151 | ||
| 0.079 | 0.052 | 0.114 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.114 0.031 DBMET00151 | DBMET00151 | |
| 0.035 | 0.007 | 0.035 | Retinoid X gamma receptor antagonist | 0.031 0.011 DBMET00151 | ||
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | 0.052 0.044 DBMET00151 | ||
| 0.031 | 0.004 | 0.031 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET00151 | ||
| 0.041 | 0.015 | 0.041 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET00151 | ||
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR4) antagonist | |||
| 0.043 | 0.018 | 0.047 | Nicotinic acid receptor 2 agonist | 0.047 0.015 DBMET00151 | DBMET00151 | |
| 0.034 | 0.008 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.027 0.017 DBMET00151 | ||
| 0.075 | 0.049 | 0.084 | CDC25A inhibitor | 0.084 0.039 DBMET00151 | DBMET00151 | |
| 0.063 | 0.038 | 0.063 | Carbonic anhydrase stimulant | |||
| 0.038 | 0.013 | 0.04 | Glutamate (mGluR3) agonist | 0.04 0.009 DBMET00151 | DBMET00151 | |
| 0.064 | 0.039 | 0.064 | TRPA1 antagonist | 0.061 0.041 DBMET00151 | ||
| 0.039 | 0.015 | 0.039 | Factor VII inhibitor | 0.032 0.019 DBMET00151 | ||
| 0.065 | 0.041 | 0.065 | Calcium channel P-type blocker | |||
| 0.057 | 0.033 | 0.057 | Acetyl-CoA transferase inhibitor | |||
| 0.06 | 0.037 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 DBMET00151 | ||
| 0.038 | 0.016 | 0.038 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.021 DBMET00151 | ||
| 0.037 | 0.015 | 0.037 | Prostaglandin agonist | 0.034 0.018 DBMET00151 | ||
| 0.048 | 0.026 | 0.048 | Carbonic anhydrase IV inhibitor | 0.04 0.032 DBMET00151 | ||
| 0.037 | 0.016 | 0.037 | AMPA 3 receptor antagonist | |||
| 0.061 | 0.04 | 0.061 | Prostaglandin EP2 antagonist | 0.054 0.047 DBMET00151 | ||
| 0.044 | 0.024 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.017 DBMET00151 | DBMET00151 | |
| 0.035 | 0.015 | 0.035 | Glutamate (mGluR2) antagonist | 0.027 0.026 DBMET00151 | ||
| 0.029 | 0.009 | 0.029 | Glutamate (mGluR1a) agonist | 0.02 0.019 DBMET00151 | ||
| 0.045 | 0.026 | 0.045 | Guanylate cyclase inhibitor | 0.039 0.035 DBMET00152 | ||
| 0.024 | 0.005 | 0.024 | CXC chemokine 5 receptor antagonist | |||
| 0.024 | 0.005 | 0.033 | Nicotinic acid receptor 1 antagonist | 0.033 0.004 DBMET00151 | DBMET00151 | |
| 0.035 | 0.016 | 0.035 | Prostaglandin D2 agonist | 0.032 0.019 DBMET00151 | ||
| 0.031 | 0.012 | 0.031 | Prostaglandin H2 antagonist | |||
| 0.052 | 0.034 | 0.052 | Thromboxane A2 antagonist | |||
| 0.032 | 0.014 | 0.032 | Lysine carboxypeptidase inhibitor | 0.027 0.018 DBMET00151 | ||
| 0.06 | 0.043 | 0.06 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.029 | 0.013 | 0.029 | Prostaglandin EP2 agonist | 0.022 0.016 DBMET00151 | ||
| 0.077 | 0.061 | 0.104 | Glycine receptor antagonist | 0.104 0.029 DBMET00152 | DBMET00152 | |
| 0.037 | 0.021 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.097 | 0.081 | 0.124 | Protein-tyrosine phosphatase 1B inhibitor | 0.124 0.06 DBMET00151 0.114 0.067 DBMET00152 | DBMET00151 | |
| 0.05 | 0.033 | 0.06 | Topoisomerase II beta inhibitor | 0.06 0.022 DBMET00151 | DBMET00151 | |
| 0.107 | 0.091 | 0.281 | Amylase inhibitor | 0.174 0.053 DBMET00151 0.281 0.021 DBMET00152 | DBMET00152 | |
| 0.089 | 0.073 | 0.089 | Interleukin 1 beta converting enzyme inhibitor | 0.084 0.083 DBMET00151 | ||
| 0.025 | 0.01 | 0.025 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.043 | 0.028 | 0.043 | GABA B receptor antagonist | |||
| 0.083 | 0.068 | 0.083 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.075 DBMET00151 | ||
| 0.072 | 0.058 | 0.072 | Vanilloid 4 agonist | |||
| 0.056 | 0.041 | 0.056 | Leukotriene C antagonist | 0.056 0.04 DBMET00151 | ||
| 0.201 | 0.187 | 0.201 | Calpain 2 inhibitor | |||
| 0.042 | 0.028 | 0.042 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.055 | 0.041 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET00151 | ||
| 0.019 | 0.005 | 0.019 | 5 Lipoxygenase activating protein inhibitor | 0.014 0.009 DBMET00151 | ||
| 0.089 | 0.075 | 0.288 | UDP-glucose 4-epimerase inhibitor | 0.087 0.078 DBMET00151 0.288 0.011 DBMET00152 | DBMET00152 | |
| 0.102 | 0.088 | 0.157 | Microtubule formation inhibitor | 0.157 0.034 DBMET00152 | DBMET00152 | |
| 0.052 | 0.04 | 0.057 | Leukotriene B4 antagonist | 0.057 0.031 DBMET00151 0.052 0.039 DBMET00152 | DBMET00151 | |
| 0.053 | 0.041 | 0.053 | Epithelial sodium channel blocker | 0.053 0.042 DBMET00151 | ||
| 0.098 | 0.086 | 0.11 | Adenylate cyclase inhibitor | 0.11 0.075 DBMET00151 | DBMET00151 | |
| 0.099 | 0.087 | 0.142 | DNA polymerase I inhibitor | 0.132 0.06 DBMET00151 0.142 0.054 DBMET00152 | DBMET00152 | |
| 0.027 | 0.016 | 0.041 | Thyroid hormone agonist | 0.041 0.006 DBMET00151 | DBMET00151 | |
| 0.033 | 0.022 | 0.033 | Carboxypeptidase B inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | 0.026 0.023 DBMET00151 | ||
| 0.043 | 0.032 | 0.043 | Geranyltranstransferase inhibitor | |||
| 0.025 | 0.014 | 0.025 | Prostaglandin E2 agonist | 0.022 0.017 DBMET00151 | ||
| 0.088 | 0.078 | 0.088 | Electrolyte absorption antagonist | |||
| 0.091 | 0.081 | 0.154 | Estrogen receptor beta antagonist | 0.154 0.015 DBMET00151 | DBMET00151 | |
| 0.108 | 0.098 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.034 | 0.024 | 0.034 | Fumarate hydratase inhibitor | |||
| 0.027 | 0.017 | 0.027 | Prostaglandin EP4 antagonist | |||
| 0.018 | 0.009 | 0.02 | Thyroid hormone alpha agonist | 0.02 0.007 DBMET00151 | DBMET00151 | |
| 0.041 | 0.032 | 0.044 | DNA gyrase subunit A inhibitor | 0.044 0.025 DBMET00151 | DBMET00151 | |
| 0.034 | 0.025 | 0.034 | Glutamate (mGluR group II) agonist | |||
| 0.1 | 0.091 | 0.153 | MAO inhibitor | 0.153 0.059 DBMET00151 | DBMET00151 | |
| 0.035 | 0.026 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 DBMET00152 | DBMET00152 | |
| 0.135 | 0.127 | 0.382 | Hepatoprotectant | 0.171 0.088 DBMET00151 0.382 0.015 DBMET00152 | DBMET00152 | |
| 0.104 | 0.096 | 0.11 | Transcription factor STAT6 inhibitor | 0.11 0.08 DBMET00151 | DBMET00151 | |
| 0.017 | 0.009 | 0.017 | Calcium-sensing receptor antagonist | 0.015 0.01 DBMET00151 | ||
| 0.107 | 0.1 | 0.107 | Nav1.2 sodium channel blocker | |||
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET00151 | ||
| 0.039 | 0.032 | 0.039 | Integrin antagonist | |||
| 0.036 | 0.029 | 0.051 | NMDA receptor subunit 3A antagonist | 0.051 0.019 DBMET00151 | DBMET00151 | |
| 0.059 | 0.052 | 0.07 | CDC25B inhibitor | 0.07 0.038 DBMET00151 | DBMET00151 | |
| 0.07 | 0.064 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.088 | 0.081 | 0.121 | Phosphodiesterase 6D inhibitor | 0.092 0.07 DBMET00151 0.121 0.024 DBMET00152 | DBMET00152 | |
| 0.04 | 0.034 | 0.04 | Glutamate (mGluR group III) agonist | |||
| 0.049 | 0.043 | 0.049 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.088 | 0.082 | 0.102 | Anabolic | 0.102 0.06 DBMET00151 | DBMET00151 | |
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.051 | 0.045 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.024 | 0.019 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.043 | 0.038 | 0.043 | Glycine transporter inhibitor | |||
| 0.087 | 0.082 | 0.102 | Urease inhibitor | 0.102 0.065 DBMET00151 | DBMET00151 | |
| 0.036 | 0.032 | 0.036 | GABA uptake inhibitor | |||
| 0.019 | 0.014 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.022 0.012 DBMET00151 | DBMET00151 | |
| 0.032 | 0.028 | 0.036 | RNA-directed RNA polymerase inhibitor | 0.036 0.022 DBMET00151 | DBMET00151 | |
| 0.027 | 0.024 | 0.027 | Prostaglandin EP3 antagonist | |||
| 0.055 | 0.051 | 0.055 | Glutamate (mGluR) agonist | |||
| 0.014 | 0.01 | 0.015 | Integrin beta6 antagonist | 0.015 0.008 DBMET00151 | DBMET00151 | |
| 0.027 | 0.024 | 0.033 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DBMET00151 | DBMET00151 | |
| 0.231 | 0.228 | 0.335 | Calcium channel L-type activator | 0.335 0.129 DBMET00151 | DBMET00151 | |
| 0.074 | 0.072 | 0.075 | Glutathione S-transferase inhibitor | 0.075 0.07 DBMET00151 | DBMET00151 | |
| 0.029 | 0.026 | 0.029 | Glutamate (mGluR2) agonist | |||
| 0.073 | 0.071 | 0.073 | Calcium antagonist | |||
| 0.02 | 0.018 | 0.02 | Integrin alphaVbeta3 antagonist | |||
| 0.05 | 0.049 | 0.05 | Dihydroorotate oxidase inhibitor | |||
| 0.069 | 0.068 | 0.069 | Metalloproteinase-2 inhibitor | 0.069 0.068 DBMET00151 | ||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.053 | 0.052 | 0.053 | Collagenase 3 inhibitor | |||
| 0.041 | 0.042 | 0.046 | Purinergic P2X4 antagonist | 0.046 0.032 DBMET00151 | DBMET00151 | |
| 0.058 | 0.058 | 0.072 | Leukotriene synthesis inhibitor | 0.072 0.043 DBMET00151 | DBMET00151 | |
| 0.057 | 0.057 | 0.06 | Heme oxygenase stimulant | 0.06 0.046 DBMET00151 | DBMET00151 | |
| 0.117 | 0.118 | 0.145 | Protein-tyrosine phosphatase inhibitor | 0.145 0.084 DBMET00151 | DBMET00151 | |
| 0.013 | 0.014 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.011 DBMET00151 | DBMET00151 | |
| 0.073 | 0.075 | 0.099 | NMDA receptor antagonist | 0.099 0.048 DBMET00151 | DBMET00151 | |
| 0.006 | 0.011 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00151 | DBMET00151 | |
| 0.12 | 0.125 | 0.134 | Adenylate cyclase stimulant | 0.134 0.093 DBMET00151 | DBMET00151 | |
| 0.116 | 0.122 | 0.316 | Hemostatic | 0.316 0.014 DBMET00152 | DBMET00152 | |
| 0.025 | 0.031 | 0.032 | HCV NS5B polymerase inhibitor | 0.032 0.021 DBMET00151 | DBMET00151 | |
| 0.113 | 0.121 | 0.208 | Anticoagulant | 0.208 0.05 DBMET00152 | DBMET00152 | |
| 0.082 | 0.091 | 0.137 | Mediator release inhibitor | 0.101 0.069 DBMET00151 0.137 0.035 DBMET00152 | DBMET00152 | |
| 0.032 | 0.04 | 0.067 | Estradiol 17 beta-dehydrogenase inhibitor | 0.067 0.017 DBMET00151 | DBMET00151 | |
| 0.026 | 0.035 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET00152 | DBMET00152 | |
| 0.049 | 0.059 | 0.058 | Androgen agonist | 0.058 0.043 DBMET00151 | DBMET00151 | |
| 0.012 | 0.021 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET00152 | DBMET00152 | |
| 0.091 | 0.101 | 0.194 | Alkylator | 0.099 0.089 DBMET00151 0.194 0.028 DBMET00152 | DBMET00152 | |
| 0.015 | 0.026 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.01 DBMET00151 | DBMET00151 | |
| 0.014 | 0.027 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.033 0.011 DBMET00151 | DBMET00151 | |
| 0.021 | 0.036 | 0.079 | Sodium/glucose cotransporter inhibitor | 0.079 0.004 DBMET00152 | DBMET00152 | |
| 0.044 | 0.059 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 DBMET00152 | DBMET00152 | |
| 0.041 | 0.057 | 0.062 | Aromatase inhibitor | 0.062 0.04 DBMET00151 | DBMET00151 | |
| 0.075 | 0.092 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 DBMET00152 | DBMET00152 | |
| 0.019 | 0.039 | 0.085 | Sodium/glucose cotransporter 2 inhibitor | 0.085 0.004 DBMET00152 | DBMET00152 | |
| 0.066 | 0.088 | 0.103 | MAO B inhibitor | 0.103 0.058 DBMET00151 | DBMET00151 | |
| 0.011 | 0.034 | 0.016 | Telomerase stimulant | 0.016 0.014 DBMET00152 | DBMET00152 | |
| 0.083 | 0.107 | 0.17 | Toll-Like receptor 4 antagonist | 0.106 0.06 DBMET00151 0.17 0.013 DBMET00152 | DBMET00152 | |
| 0.178 | 0.204 | 0.351 | Vasodilator, coronary | 0.351 0.055 DBMET00152 | DBMET00152 | |
| 0.119 | 0.146 | 0.444 | Platelet adhesion inhibitor | 0.139 0.12 DBMET00151 0.444 0.008 DBMET00152 | DBMET00152 | |
| 0.125 | 0.155 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.113 DBMET00151 | DBMET00151 | |
| 0.088 | 0.122 | 0.122 | Bone formation stimulant | 0.122 0.084 DBMET00151 | DBMET00151 | |
| 0.027 | 0.061 | 0.053 | Phosphorylase inhibitor | 0.053 0.029 DBMET00152 | DBMET00152 | |
| 0.017 | 0.052 | 0.024 | Vanilloid 2 agonist | 0.024 0.021 DBMET00152 | DBMET00152 | |
| 0.019 | 0.053 | 0.053 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.053 0.014 DBMET00151 | DBMET00151 | |
| 0.075 | 0.109 | 0.101 | Xanthine oxidase inhibitor | 0.101 0.059 DBMET00151 0.094 0.065 DBMET00152 | DBMET00151 | |
| 0.099 | 0.134 | 0.183 | DNA repair enzyme inhibitor | 0.183 0.012 DBMET00152 | DBMET00152 | |
| 0.025 | 0.063 | 0.038 | Dopamine D5 agonist | 0.038 0.031 DBMET00151 | DBMET00151 | |
| 0.029 | 0.068 | 0.064 | Mannosidase inhibitor | 0.064 0.015 DBMET00152 | DBMET00152 | |
| 0.144 | 0.183 | 0.213 | DNA damaging | 0.213 0.105 DBMET00152 | DBMET00152 | |
| 0.079 | 0.119 | 0.099 | Nav1.4 sodium channel blocker | 0.099 0.077 DBMET00151 | DBMET00151 | |
| 0.063 | 0.103 | 0.097 | MAO A inhibitor | 0.097 0.066 DBMET00151 | DBMET00151 | |
| 0.047 | 0.087 | 0.069 | Histidine decarboxylase inhibitor | 0.069 0.052 DBMET00151 | DBMET00151 | |
| 0.024 | 0.067 | 0.099 | Estrogen agonist | 0.099 0.017 DBMET00151 | DBMET00151 | |
| 0.009 | 0.052 | 0.072 | Estrogen receptor alpha agonist | 0.072 0.013 DBMET00151 | DBMET00151 | |
| 0.047 | 0.09 | 0.066 | Lipocortins synthesis agonist | 0.066 0.027 DBMET00152 | DBMET00152 | |
| 0.031 | 0.074 | 0.055 | Xanthine dehydrogenase inhibitor | 0.055 0.042 DBMET00151 | DBMET00151 | |
| 0.047 | 0.092 | 0.092 | Na+ K+ transporting ATPase inhibitor | 0.092 0.039 DBMET00152 | DBMET00152 | |
| 0.072 | 0.121 | 0.176 | Topoisomerase II inhibitor | 0.127 0.062 DBMET00151 0.176 0.039 DBMET00152 | DBMET00152 | |
| 0.034 | 0.084 | 0.056 | HIV-1 integrase (Strand Transfer) inhibitor | 0.056 0.045 DBMET00151 | DBMET00151 | |
| 0.04 | 0.091 | 0.065 | Lipase inhibitor | 0.065 0.059 DBMET00152 | DBMET00152 | |
| 0.043 | 0.096 | 0.088 | Adenine nucleotide translocase inhibitor | 0.088 0.006 DBMET00152 | DBMET00152 | |
| 0.008 | 0.065 | 0.077 | Estrogen receptor beta agonist | 0.077 0.015 DBMET00151 | DBMET00151 | |
| 0.011 | 0.071 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00152 | DBMET00152 | |
| 0.009 | 0.071 | 0.031 | Squalene synthetase inhibitor | 0.031 0.023 DBMET00152 | DBMET00152 | |
| 0.033 | 0.104 | 0.106 | Glucose-6-phosphate translocase inhibitor | 0.106 0.005 DBMET00152 | DBMET00152 | |
| 0.026 | 0.101 | 0.092 | Protein 50S ribosomal subunit inhibitor | 0.092 0.015 DBMET00152 | DBMET00152 | |
| 0.069 | 0.145 | 0.231 | Beta glucuronidase inhibitor | 0.091 0.085 DBMET00151 0.231 0.01 DBMET00152 | DBMET00152 | |
| 0.1 | 0.18 | 0.169 | DNA methyltransferase I inhibitor | 0.169 0.087 DBMET00152 | DBMET00152 | |
| 0.118 | 0.207 | 0.146 | Catenin beta inhibitor | 0.146 0.115 DBMET00151 | DBMET00151 | |
| 0.194 | 0.283 | 0.645 | Apoptosis agonist | 0.289 0.181 DBMET00151 0.645 0.04 DBMET00152 | DBMET00152 | |
| 0.136 | 0.23 | 0.203 | 12-Lipoxygenase inhibitor | 0.203 0.148 DBMET00151 | DBMET00151 | |
| 0.104 | 0.212 | 0.403 | Immunostimulant | 0.403 0.049 DBMET00152 | DBMET00152 | |
| 0.017 | 0.127 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 DBMET00152 | DBMET00152 | |
| 0.153 | 0.268 | 0.226 | Caspase 3 stimulant | 0.213 0.15 DBMET00151 0.226 0.135 DBMET00152 | DBMET00152 | |
| 0.075 | 0.196 | 0.598 | Angiogenesis stimulant | 0.136 0.132 DBMET00151 0.598 0.007 DBMET00152 | DBMET00152 | |
| 0.022 | 0.148 | 0.049 | Microtubule stabilization | 0.049 0.029 DBMET00152 | DBMET00152 | |
| 0.027 | 0.16 | 0.085 | Factor IXa inhibitor | 0.085 0.014 DBMET00152 | DBMET00152 | |
| 0.088 | 0.224 | 0.22 | DNA methylase inhibitor | 0.22 0.066 DBMET00152 | DBMET00152 | |
| 0.018 | 0.206 | 0.33 | Selectin antagonist | 0.33 0.004 DBMET00152 | DBMET00152 | |
| 0.014 | 0.231 | 0.158 | Antineoplastic antibiotic | 0.158 0.029 DBMET00152 | DBMET00152 | |
| 0.111 | 0.355 | 0.337 | Peptidyltransferase inhibitor | 0.337 0.014 DBMET00152 | DBMET00152 | |
| 0.022 | 0.268 | 0.077 | Topoisomerase II alpha inhibitor | 0.077 0.055 DBMET00152 | DBMET00152 | |
| 0.014 | 0.265 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET00152 | DBMET00152 | |
| 0.062 | 0.318 | 0.153 | P-glycoprotein inhibitor | 0.153 0.113 DBMET00152 | DBMET00152 | |
| 0.044 | 0.304 | 0.121 | Transcription factor NF kappa B stimulant | 0.121 0.025 DBMET00152 | DBMET00152 | |
| 0.05 | 0.332 | 0.113 | Interleukin 4 antagonist | 0.113 0.097 DBMET00152 | DBMET00152 | |
| 0.035 | 0.33 | 0.274 | Lipid peroxidase inhibitor | 0.274 0.023 DBMET00152 | DBMET00152 | |
| 0.022 | 0.326 | 0.222 | Topoisomerase I inhibitor | 0.222 0.022 DBMET00152 | DBMET00152 | |
| 0.032 | 0.337 | 0.132 | Multidrug resistance-associated protein 1 inhibitor | 0.132 0.036 DBMET00152 | DBMET00152 | |
| 0.089 | 0.417 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.046 DBMET00152 | DBMET00152 | |
| 0.011 | 0.407 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET00152 | DBMET00152 | |
| 0.011 | 0.526 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 DBMET00152 | DBMET00152 | |
| 0.039 | 0.557 | 0.202 | Angiogenesis inhibitor | 0.202 0.167 DBMET00152 | DBMET00152 | |
| 0.005 | 0.53 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 DBMET00152 | DBMET00152 | |
| 0.029 | 0.579 | 0.356 | Tumour necrosis factor alpha release inhibitor | 0.356 0.036 DBMET00152 | DBMET00152 | |
| 0.01 | 0.791 | 0.18 | Vasodilator | 0.18 0.122 DBMET00152 | DBMET00152 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |